Axonics Research and Development Expenses 2017-2023 | AXNX
Axonics research and development expenses from 2017 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Axonics Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $35 |
| 2022 | $34 |
| 2021 | $37 |
| 2020 | $29 |
| 2019 | $20 |
| 2018 | $19 |
| 2017 | $12 |
| 2016 | $13 |
| Axonics Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | $10 |
| 2023-09-30 | $8 |
| 2023-06-30 | $9 |
| 2023-03-31 | $8 |
| 2022-12-31 | $8 |
| 2022-09-30 | $8 |
| 2022-06-30 | $7 |
| 2022-03-31 | $11 |
| 2021-12-31 | $10 |
| 2021-09-30 | $9 |
| 2021-06-30 | $9 |
| 2021-03-31 | $9 |
| 2020-12-31 | $8 |
| 2020-09-30 | $8 |
| 2020-06-30 | $6 |
| 2020-03-31 | $7 |
| 2019-12-31 | $6 |
| 2019-09-30 | $5 |
| 2019-06-30 | $5 |
| 2019-03-31 | $4 |
| 2018-12-31 | $5 |
| 2018-09-30 | $4 |
| 2018-06-30 | $6 |
| 2018-03-31 | $5 |
| 2017-12-31 | |
| 2017-09-30 | $3 |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.453B | $0.366B |
| Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.389B | 20.53 |
| Inspire Medical Systems (INSP) | United States | $4.746B | 0.00 |
| 10x Genomics (TXG) | United States | $3.145B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.129B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.985B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.973B | 0.00 |
| Enovis (ENOV) | United States | $2.887B | 21.40 |
| Azenta (AZTA) | United States | $2.782B | 156.36 |
| Privia Health (PRVA) | United States | $2.073B | 115.80 |
| Schrodinger (SDGR) | United States | $1.698B | 0.00 |
| Omnicell (OMCL) | United States | $1.372B | 47.41 |
| Phreesia (PHR) | United States | $1.370B | 0.00 |
| Standard BioTools (LAB) | United States | $0.734B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.675B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.657B | 0.00 |
| Talkspace (TALK) | United States | $0.489B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.469B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.400B | 0.00 |
| Pulmonx (LUNG) | United States | $0.362B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.303B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.219B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.194B | 0.00 |
| Outset Medical (OM) | United States | $0.184B | 0.00 |
| American Well (AMWL) | United States | $0.142B | 0.00 |
| TruBridge (TBRG) | United States | $0.134B | 7.22 |
| MSP Recovery (LIFW) | United States | $0.111B | 0.00 |
| 111 (YI) | China | $0.109B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.072B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.072B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.068B | 0.00 |
| Augmedix (AUGX) | United States | $0.058B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.058B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.046B | 0.00 |
| CareCloud (CCLD) | United States | $0.036B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Cue Health (HLTH) | United States | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.015B | 0.00 |
| Syra Health (SYRA) | United States | $0.011B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |